Literature DB >> 19141263

Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography.

Po-Tsang Lee1, Kang-Ju Chou, Hua-Chang Fang.   

Abstract

Although contrast-induced nephropathy (CIN) is usually self-limited, it may cause permanent renal injury and even lead to long-term dialysis in patients with preexisting renal impairment. Cardiologists face a dilemma as to whether to alleviate coronary syndromes by coronary intervention or to risk CIN in these patients. Strategies to prevent CIN, including hydration, use of low-osmolal or iso-osmolal contrast media, administration of N-acetylcysteine, and blood purification procedures, were proposed to be effective; however, there are conflicting results. Recently, we found that prophylactic hemodialysis could significantly improve renal survival in patients with advanced renal insufficiency undergoing coronary angiography in a randomized controlled trial. In these patients, fluid supplementation is poorly tolerated and impractical, especially in those with poor heart function. However, the routine use of prophylactic hemodialysis in patients with mild renal insufficiency requires further investigation.

Entities:  

Year:  2009        PMID: 19141263     DOI: 10.1007/s11936-009-0008-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  49 in total

Review 1.  Risk prediction of contrast-induced nephropathy.

Authors:  Peter A McCullough; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Fulvio Stacul; James Tumlin
Journal:  Am J Cardiol       Date:  2006-02-23       Impact factor: 2.778

2.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Authors:  George Dangas; Ioannis Iakovou; Eugenia Nikolsky; Eve D Aymong; Gary S Mintz; Nicholas N Kipshidze; Alexandra J Lansky; Issam Moussa; Gregg W Stone; Jeffrey W Moses; Martin B Leon; Roxana Mehran
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

3.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

4.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

Review 5.  Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.

Authors:  Richard Solomon; William Dumouchel
Journal:  Invest Radiol       Date:  2006-08       Impact factor: 6.016

6.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.

Authors:  L Gruberg; G S Mintz; R Mehran; G Gangas; A J Lansky; K M Kent; A D Pichard; L F Satler; M B Leon
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

7.  Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.

Authors:  Giancarlo Marenzi; Gianfranco Lauri; Jeness Campodonico; Ivana Marana; Emilio Assanelli; Monica De Metrio; Marco Grazi; Fabrizio Veglia; Franco Fabbiocchi; Piero Montorsi; Antonio L Bartorelli
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

8.  N-Acetylcysteine does not artifactually lower plasma creatinine concentration.

Authors:  Michael Haase; Anja Haase-Fielitz; Sujiva Ratnaike; Michael C Reade; Sean M Bagshaw; Stanislao Morgera; Duska Dragun; Rinaldo Bellomo
Journal:  Nephrol Dial Transplant       Date:  2008-01-17       Impact factor: 5.992

9.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

Authors:  R G Cigarroa; R A Lange; R H Williams; L D Hillis
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

10.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.

Authors:  Alejandro Recio-Mayoral; Marinela Chaparro; Belén Prado; Rocío Cózar; Irene Méndez; Debasish Banerjee; Juan C Kaski; José Cubero; Jose M Cruz
Journal:  J Am Coll Cardiol       Date:  2007-03-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.